Supercritical Fluid Chromatography for Rapid Infection Diagnosis

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current microbiological diagnostic tests for microbial infections are time-consuming, often requiring 24-48 hours for culture, which is detrimental for vulnerable patient populations such as cancer patients with febrile neutropenia, where rapid identification and initiation of appropriate therapy are critical for survival.

Innovation Solution

A method utilizing supercritical fluid chromatographic separation of quorum sensing molecules (QSMs) for rapid differential diagnosis of infections, allowing for the identification of pathogens like P. aeruginosa, S. aureus, and C. albicans without the need for time-consuming culture, using SFC/MS analysis to detect and quantify these biomarkers in clinical specimens.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional microbiological culture methods are used for diagnostic testing, then identification accuracy is improved, but diagnosis time increases to 24-48 hours or more

Engineering Contradiction:
Improveidentification accuracyVSAvoiddiagnosis time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The invention extracts and detects specific quorum sensing molecules (N-acyl homoserine lactones) as biomarkers directly from patient specimens using supercritical fluid chromatography coupled with mass spectrometry. This extraction approach bypasses the need for time-consuming microbial culture while maintaining pathogen identification capability, reducing diagnosis time from 24-48 hours to a rapid analysis process.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention uses quorum sensing molecules as intermediary biomarkers that indicate the presence of specific pathogens. Instead of directly detecting the microorganisms themselves through culture, the method detects these chemical signaling molecules that mediate between the pathogen and the diagnostic test, enabling rapid identification without waiting for microbial growth.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If rapid diagnostic methods are implemented, then diagnosis speed is improved, but detection precision may deteriorate

Engineering Contradiction:
Improvediagnosis speedVSAvoiddetection precision
Core Design Contradiction:
ProductivityVSMeasurement precision

Solution Approach 1:

The invention replaces the mechanical/biological process of microbial culture with a chemical analysis system using supercritical fluid chromatography and mass spectrometry. This substitution enables rapid detection by analyzing chemical biomarkers directly, achieving both speed and precision simultaneously rather than relying on slow biological growth processes.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The invention changes the detection parameter from observing microbial growth (time-dependent) to detecting specific chemical molecules (concentration-dependent). By measuring the presence and concentration of quorum sensing molecules through mass spectrometry, the method achieves rapid results with high precision, transforming the diagnostic parameter from temporal to chemical.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Enables rapid, culture-free diagnosis of infections, directing immediate and appropriate antibiotic or antimycotic therapy, reducing mortality risks by providing timely identification of infectious agents and their biofilm involvement.

Implementation Method 1

supercritical fluid chromatographic separation of biomarkers

Methodology Applied
Scientific EffectChromatography: Chromatography

Implementation Method 2

using supercritical fluid chromatographic separation

Methodology Applied
Scientific EffectSupercritical fluid extraction: Supercritical Fluid Extraction

Implementation Method 3

SFC/MS analysis to detect and quantify these biomarkers

Methodology Applied
Scientific EffectMass spectrometry:

Data Source

PatentUS11360062B2Method for rapid differential diagnosis of infection using supercritical fluid chromatographic separation of microbial quorum sensing molecules
Publication Date: 2022.06.14 STC UNM
  • US11360062B2 patent drawing
  • US11360062B2 patent drawing
  • US11360062B2 patent drawing

AI summary

A method for rapid differential diagnosis of infection using supercritical fluid chromatographic separation of quorum sensing molecules as biomarkers for infection agents.